INTERNATIONAL PATENT: TAKEDA PHARMACEUTICAL COMPANY LIMITED FILES APPLICATION FOR "COMPOSITIONS OF ENGINEERED CYTOKINE EXPRESSING CELLS AND METHODS OF USE THEREOF"

GENEVA, May 4 -- TAKEDA PHARMACEUTICAL COMPANY LIMITED (1-1, Doshomachi 4-chomeChuo-kuOsaka-shi, Osaka 541-8645) filed a patent application (PCT/IB2025/060870) for "COMPOSITIONS OF ENGINEERED CYTOKINE EXPRESSING CELLS AND METHODS OF USE THEREOF" on Oct 24, 2025. With publication no. WO/2026/088163, the details related to the patent application was published on Apr 30, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WANG, Yana (c/o Takeda Development Center Americas, Inc.500 Kendall StreetCambridge, Massachusetts 02142), ZHU, Zengrong (c/o Takeda Development Center Americas, Inc.500 Kendall S...